Join us as we return to Vienna, a globally recognized meeting destination and one of Europe's premier life science hubs. The city is home to the renowned Vienna BioCenter, a nexus of academic research and over 50 innovative biotech companies, alongside industry leaders like Boehringer Ingelheim, Takeda and Novartis. This powerful combination of scientific excellence, seamless accessibility, and rich...
42 events found.
Events
Calendar of Events
|
Sunday
|
Monday
|
Tuesday
|
Wednesday
|
Thursday
|
Friday
|
Saturday
|
|---|---|---|---|---|---|---|
|
0 events,
|
3 events,
-
Moving patients successfully from initial interest to randomization is one of the most critical and challenging steps in psychiatry clinical trials. Many studies experience significant drop-off during the qualification and screening stages due to strict eligibility criteria, incomplete patient information, and inefficient referral processes. This webinar focuses on strategies to improve patient qualification and increase...
Free
-
Explore how innovative CMC strategies are transforming early antibody development. Learn how an integrated approach can accelerate the path from DNA to IND to as little as six months, without compromising quality or regulatory alignment. Backed by over 30 years of biologics expertise, this session will highlight cutting-edge technologies, platform-driven workflows, and parallel development strategies...
Free
|
6 events,The 3rd Biophysics for Drug Discovery Summit offers a rare, highly technical, industry-focused forum dedicated solely to biophysics. Unlike broader drug discovery meetings, this summit provides a comprehensive view of techniques, emerging technologies, and practical applications. Through case studies, panel discussions, and interactive dialogue, attendees will explore how next-generation biophysics drives predictive pipelines and accelerates discovery. To... A Decade of Expertise, Now in China: Cell & Gene Therapy Summit 2026 With over a decade of experience hosting premier cell and gene therapy events in the US and Europe, attracting 1,500+ attendees annually, Cell & Gene Therapy International is bringing its expertise to China. The 2026 summit in Shanghai is designed to foster collaboration... The ChinaBio Partnering Forum is China's premier life science event, connecting global biopharma with China's market for strategic partnerships, investment, and innovation, featuring partneringONE technology, company pitches (like Startup Spotlight), expert panels, and networking to accelerate cross-border deals.
-
What You'll Learn: Mapping the Next Frontier of Growth: How Southern California’s biotech, pharma, therapeutics and medtech industries are evolving, and which markets are maturing fastest. Commercial Real Estate Outlook: How landlords, developers and owners are adapting to laboratory and biomanufacturing requirements in a rapidly advancing industry. Funding & Investment Conditions: Who is investing, what...
-
Despite nearly two decades of industry surveys demonstrating a steady demand for new and improved single-use technologies, next-generation films, polymers, and components struggle to achieve widespread adoption. Join Bioprocess Online’s Tyler Menichiello for an interactive panel discussion examining how regulatory lag, evolving biocompatibility standards, and the complexity of converting legacy systems slow the uptake of... |
7 events,
-
As clinical trials become increasingly outsourced, a critical gap has emerged between sponsor expectations and CRO execution. Many smaller biotech companies rely heavily on outsourcing vendors to drive their programs, often without the internal clinical operations infrastructure needed to provide direction, oversight, and strategic alignment. At the same time, vendor teams—particularly CRAs—are frequently stretched thin...
Free
-
Driving Smarter Chemistry in Drug Discovery: Using Full DEL Data to Improve Early Compound Decisions
Driving Smarter Chemistry in Drug Discovery: Using Full DEL Data to Improve Early Compound Decisions
Modern screening approaches generate rich datasets that capture how large collections of compounds interact with biological targets. However, discovery teams often rely on only a small portion of that information when selecting compounds for synthesis, potentially missing important signals across the broader dataset. In this webinar, we explore how evaluating the full screening landscape can...
Free
-
Research findings from 150 manufacturing leaders uncovered a "connectivity crisis" preventing production optimization. This webinar addresses the imperative to break down the silos today that are creating the delays, rework, and compliance issues that 90%-plus manufacturers struggle with. Start at the bottom and build the connected data foundation that makes AI actually work.
Free
|
7 events,
-
Radiopharmaceuticals and radioligand therapies were involved in multibillion dollar M&A transactions over the last several years. Panelists on this Life Science Leader virtual event will discuss emerging technologies and radioisotopes, what new market opportunities exist, and what manufacturing and delivery challenges remain for radiopharmaceutical developers. Registered attendees will have the opportunity to pose their own... 
Featured
-
Featured
In this session, explore how digitally connected execution ecosystems move manufacturers from reactive response to proactive control, enabling faster decisions, fewer errors, and inspection-ready operations by design.
-
Discover how precision genome editing is advancing the next generation of genetic medicines. Learn strategies to achieve highly specific, potent DNA edits while minimizing off-target effects and meeting rigorous safety standards for clinical translation. What you’ll learn: - How to precisely correct disease mutations without creating unwanted edits - Engineering and optimizing DNA recognition to...
Free
|
0 events,
|
0 events,
|
|
0 events,
|
4 events,
Featured
Join us for an exclusive gathering of senior-level investors, pharma executives, entrepreneurs, research thought leaders, and innovators at the 33rd Annual TRI-CON. Connect with investors and partners at intimate networking sessions; gain strategic insights on funding activities, business development, and innovation strategies in diagnostics, precision medicine, and AI from industry-led panels; and hear candid perspectives... Join our SynBioBeta community for three days of high-signal talks, curated 1:1 meetings, real partnering, and hands-on exposure at the frontier of biology and technology. Go deep on AI-driven biology and therapeutics. You’ll also get up to speed on sustainable biomanufacturing of chemicals, materials, food, and consumer products, and discover applications of biology that you...
-
A practical look at overcoming viscosity, fouling, and aggregation with modern TFF platforms. As monoclonal antibody therapies continue to evolve, the industry is rapidly shifting from traditional mAb formulations to high‑concentration mAbs to enable subcutaneous delivery, improve patient convenience, and support next‑generation therapeutics. While this shift delivers clear clinical benefits, it also introduces new risks...
-
Selective gene delivery to defined cell populations using targeted lentiviral vectors (LVV) represents a promising strategy for next‑generation immunotherapies such as chimeric antigen receptor (CAR) T‑cell therapy. While conventional CAR-T cell manufacturing requires multiple ex vivo manipulation steps up to two weeks, targeted LVVs can enable a short ex vivo manufacturing process or direct in... |
3 events,
-
Microphysiological (MPS) systems are proving to be increasingly valuable for early drug discovery. By recreating human‑specific physiology—fluid flow, barrier function, multicellular interactions, and organ‑level mechanics—organ‑on‑chip models generate insight that’s difficult to obtain from traditional cell lines or animals. They support target validation research and they enable early efficacy modeling for processes like neuroinflammation, fibrosis, barrier...
Free
|
3 events,
-
Explore why regional supply chain diversification and strong CDMO partnerships are no longer optional, but essential for resilience, speed, and compliance in 2026. Hear directly from top industry experts and CDMO leaders as they share actionable strategies, real-world insights, and urgent steps companies must take to secure capacity, reduce risk, and stay competitive.
Free
-
In bio-process control, including mammalian cell cultures as well as microbial fermentation, Cedex Analyzers from Roche CustomBiotech enable fast and reliable determination of the relevant media components, for optimization of the protocols and for monitoring of routine processes to achieve optimal yield and product quality. More than 30 parameters can be analyzed on the same... |
6 events,What opportunities get created as fields converge? What challenges surface as markets, policies, and investing dynamics shift? What new scientific discoveries are potential game-changers? Convergence exists to explore those questions (and many others), with a high-level audience interested in what’s happening in the rapidly-converging worlds of biotech, pharma, healthcare, medical devices, and the Internet. The...
-
Join us for a virtual expo built for clinical teams that need to evaluate Interactive Response Technology / Randomization & Trial Supply Management platforms. Selecting the right supplier is a vital decision that impacts patient safety, data integrity, and site compliance. The Clinical Leader Solutions Expo is designed to support clinical research experts in accelerating...
Free
-
Discover how integrated in silico and in vitro approaches can assess developability, manufacturability, and immunosafety at the earliest stages. Learn how a toolbox strategy enables smarter candidate selection, reduces downstream risk, and supports faster progression of multi-specific antibodies into clinical development. Key takeaways include: - Early identification of developability and immunosafety risks in multi-specific antibodies...
Free
Featured
-
Featured
This webinar invites an interactive dialogue to explore how Industrial AI can be introduced where plants are today. We’ll walk through what is real and working now to turn insights into governed, auditable actions, with human oversight by design. |
3 events,This meeting brings together the innovators and business leaders to foster collaborations and advance CGT in the Greater Philadelphia area.
-
Explore how data-driven tools and Process Analytical Technology (PAT) can optimize scale-up, enhance process control, and reduce risk from cell culture through drug product. Learn how integrating advanced modeling and real-time monitoring enables more reliable, cost-effective, and scalable biologics production. Key takeaways include: - Applying predictive, engineering-driven models to improve bioreactor scale-up and performance -...
Free
|
|
|
0 events,
|
5 events,
Featured
The PEGS Boston Summit is where the future of biologics takes shape. For over 20 years, PEGS is the go-to event for protein and antibody engineering, drug development, immunotherapy, radiotherapy, and AI/ML-driven biologics research. New in 2026: a dedicated focus on peptides, spotlighting their therapeutic power, design innovations, and expanding role in drug discovery. With... The ASGCT Annual Meeting is the leading global event for professionals in gene and cell therapy, hosted by the American Society of Gene + Cell Therapy (ASGCT) to showcase cutting-edge research, new technologies, and clinical applications, offering crucial networking for scientists, industry leaders, and clinicians to advance treatments for human diseases. It features expert presentations,... The AAPS National Biotechnology Conference (NBC) is a premier annual event by the American Association of Pharmaceutical Scientists (AAPS) for leaders in pharma and biotech to explore cutting-edge science in biologics, advanced therapies, and innovative drug development, focusing on new modalities like CAR-T, gene therapies, and AI in drug discovery, bridging research from lab to...
-
Antibody-drug conjugates (ADCs) bring together multiple scientific and operational disciplines, which makes early and ongoing outsourcing decisions especially consequential. This event examines how sponsors think through outsourcing strategies across discovery support, process development, bioconjugation, analytical work, drug substance, and fill-finish, focusing on what should remain internal and what should be outsourced to external partners. Our...
Free
-
Downstream process development is rapidly evolving as new modalities, from mAbs to mRNA, viral vectors, and other complex molecules, enter development pipelines. This webinar will share practical strategies and analytical considerations for designing robust, scalable purification processes across diverse molecule types. Drawing on decades of chromatography innovation and the expertise of our global Fast Trak™... |
8 events,Be in the Room Where Decisions Are Made Fierce Biotech Week attracts senior leaders across biotech and pharma, including: C-suite executives and founders Heads of R&D and Drug Development Clinical & TMF leadership BD&L and corporate strategy teams PR & Communications executives Strategic outsourcing partners This is not a spectator audience. It’s a room of...
-
From research to regulation, the biotech industry is taking a hit, but drug-development companies continue to press forward, moving important discoveries from the lab bench to the patient bedside. The program will begin with a talk with Ultragenyx CEO Emil Kakkis, the scientist behind the first treatment for an ultra-rare genetic disease, and Ryan Dant, the...
-
AI is making it possible to simulate clinical trials before they begin using realistic synthetic patient cohorts built from real-world data. In this session, you’ll see how these simulations compare to actual Phase 2 and Phase 3 trial data, and how teams are using them to test protocols, reduce risk, and improve study design faster....
Free
-
As cell and gene therapy companies navigate the 2026 landscape marked by manufacturing overcapacity, a strategic question is no longer if to outsource, but how. For leaders across MSAT, CMC, and technical operations, the choice between renting, leasing, or building distributed manufacturing capabilities has direct implications for speed to clinic, capital efficiency, and long-term scalability.... |
10 events,
Featured
-
Featured
At Breakthroughs in Bioprocessing, you'll have the opportunity to: Translate expertise into impact Work alongside Cytiva specialists and industry peers to explore practical, scalable approaches across bioprocess development, manufacturing, and scale-up. Experience innovation beyond theory Engage with advanced technologies in a live, interactive environment designed to support hands-on learning and real-world application. Gain insight through...
-
The informed consent process is an ongoing dialogue that helps participants decide, with full understanding, whether to take part in a clinical trial. As generative AI begins to influence how consent documents are created, translated, and delivered, this process is becoming more complex. Join experts in IRB oversight, research ethics, and health literacy to explore...
Free
-
Rapid access to early-stage material is critical for biologics development, especially as molecular complexity increases and timelines expand. Generating scalable, high-quality material early helps streamline developability assessments and process development. In this webinar, Samsung Biologics presents its strategy for early material generation, integrating it with cell line development (CLD), early optimization, and stable expression platforms....
Free
|
3 events,
-
This year, Curebound is proud to welcome one of the world’s most celebrated and beloved artists: P!NK Tickets on sale now! Since bursting onto the scene in 2000, P!NK has built a career defined by fearless honesty, unforgettable live shows, and a refusal to fit a mold. Across nine studio albums and a greatest hits collection,... |
0 events,
|
|
|
0 events,
|
0 events,
|
6 events,
Featured
The Bio-IT World Conference & Expo is the premier global event showcasing technologies and analytic approaches that solve problems, accelerate science, and drive the future of precision medicine. Now in its 25th year, the event convenes more than 2,900 leaders from biopharma, clinical research, healthcare, informatics, and technology to exchange ideas, showcase solutions, and spark... Returning for its 8th year, LEAP HR: Life Sciences West reunites 100+ senior HR leaders from scaling and stabilizing biotech organizations to uncover how to navigate volatility, unlock peer-led insights, and deliver tangible business impact. Across three days of high-impact content, you’ll gain actionable takeaways through case studies, benchmarking sessions, structured networking, roundtable discussions, and speed learning. From navigating immigration shifts and...
Featured
Health & Business Growth Summit Zagreb 2026 is an international event that brings together experts, entrepreneurs, and innovators from the healthcare and business sectors. Over the course of three days, the summit features a combination of inspiring keynote talks, panel discussions, an exhibition area, and networking opportunities, all focused on development, growth, and global expansion...
-
Clinical execution and pharmacovigilance are often managed in parallel rather than in partnership. For sponsors, that disconnect can create avoidable delays, inconsistent safety decision-making, protocol amendments, and added pressure on sites and study teams. In early-phase and complex trials, where risk profiles are still emerging, these gaps can have a direct impact on both patient...
Free
-
This online event brings together pharmaceutical and biotechnology companies with contract development and manufacturing organizations (CDMOs) specializing in mammalian cell culture–based biologics production. Through a series of concise presentations, participating CDMOs showcase their capabilities across the biologics development lifecycle, including cell line development, upstream and downstream process development, scale-up, and GMP manufacturing. The event is...
Free
-
This event brings together pharmaceutical and biotech professionals, CDMOs, and technology providers to discuss the development and manufacturing of highly potent active pharmaceutical ingredients (HPAPIs). This event shares presentations focused on key topics such as containment technologies, process scale-up, regulatory compliance, and occupational safety in HPAPI manufacturing. The event also serves as a networking platform...
Free
|
9 events,
Featured
-
Featured
What if advancing the 3Rs also improved your timelines, budgets, and scientific outcomes? This webinar challenges the perceived tradeoff between the 3Rs and operational performance in colony management. We will explore how a thoughtful combination of IVF, cryopreservation, electroporation, genotyping, and digital colony management can reduce animal use, stabilize genetic backgrounds, and simplify day to...
-
The move toward self-administered, home-based treatments has made drug–device combination products a strategic priority. Success now requires tight integration across formulation, device design, testing, human factors, and regulatory strategy—not separate workflows. This session outlines the key decisions and capabilities for successful programs, including choosing platform vs. custom devices, ensuring formulation–device compatibility, and meeting testing standards....
Free
-
BVS in partnership with Related Beal, LLC inviting you to our Biotech Community Event in the heart of Boston's Seaport district. Mark your calendars for a great opportunity to connect with industry leaders, explore innovative products, and mingle with fellow professionals in the biotech community. We are inviting all research scientists from the institutes, biotech/pharma,... |
6 events,
-
This sponsor-led webinar will explore the real-world impact of using a centralized trial services platform through firsthand experiences from both Cogent and Helus Pharma. Discover how working with a single partner to manage patient logistics, site payments, and financial coordination influenced day-to-day trial operations, communication across stakeholders, and the overall experience for sites and participants....
Free
-
Many patients continue to prefer the ease and convenience of orally administered medications and therapies. In this informative session on advances in oral drug delivery, expert panelists Jing Ling, Eduardo Jule, and Firouz Asgarzadeh will join host Tom von Gunden in a discussion of opportunities and challenges in designing oral delivery methods that a) expand...
Free
-
As demand for advanced therapies continues to surge, the biopharma industry is under pressure to innovate faster in high-risk areas like drug discovery and cell therapy. These fields face persistent challenges, such as high costs, long development timelines, and complex regulatory landscapes. To that end, MaxCyte has introduced a new high-throughput electroporation platform that streamlines...
Free
|
0 events,
|
0 events,
|
|
0 events,
|
0 events,
|
0 events,
|
3 events,
-
Antibody-drug conjugates (ADCs) present unique analytical challenges, particularly in maintaining consistent drug-to-antibody ratio (DAR), minimizing variability, and reducing reliance on time-intensive off-line methods. These challenges are further compounded by the need to limit handling of highly potent payloads while maintaining process control. This webinar explores how variable pathlength spectroscopy enables rapid, accurate at-line and in-line... 
Featured
-
Featured
This presentation focuses on the analytical strategies required to enable high-volume production, including the deployment of high-throughput chromatographic methods for impurity profiling, integration of orthogonal techniques such as LC-MS for identity confirmation, and the role of stability-indicating methods in maintaining product quality.
-
Join Us for the BVS and BioMed Realty Biotech Community Event! Mark your calendars for a great opportunity to connect with industry leaders, explore innovative products, and mingle with fellow professionals in the biotech community. The vendor fair is held at The Forum, in the same building as Amgen and next to Genentech, right in... |
4 events,Connect with innovators, investors, and companies advancing cancer breakthroughs, in person or virtually, during Chicago’s biggest oncology event through the BIO Partnering™ system.
-
Danforth Health provides the life sciences community with strategic and operational support across business, clinical and commercial functions. Moderated by: Barb Carlin, CPA, MBA, Managing Director, Mid Atlantic Region, Danforth Health 9:00 AM - 10:00 AM - Panel Discussion 10:00 AM - 10:30 AM - Networking in Zoom Breakout Rooms Questions? Contact Lauren Boyle, lboyle@lifesciencespa.org
-
Gene therapies are among the most expensive biopharmaceuticals to develop and manufacture, due in large part to persistent bottlenecks in downstream processing. When purification workflows lose 10% to 30% of vector at each unit operation, it forces developers to make critical tradeoffs to maximize yield without compromising product quality. Join Bioprocess Online on Thursday, May...
-
Pharmaceutical labeling continues to change and adapt to trends in product presentation & regulations. Considering trends in automation, product handling, and robotics, it is important to have standardized approaches to pharmaceutical labeling platforms. Rising trends in single use autoinjector devices and personalized medicines require quality design with the future in mind. Pharmaceutical labeling machines need...
Free
|
2 events,
-
Join this thought leadership panel exploring how the CAR-T landscape continues to evolve as clinical and commercial experience grows. As autologous therapies expand into additional settings and allogeneic approaches continue to be studied, organizations are reassessing where to focus research, development, and operational efforts. This discussion brings together perspectives from across the cell therapy ecosystem... |
2 events,Why Attend The 2026 SNMMI Annual Meeting will feature: Revolutionary research shaping the future of nuclear medicine and molecular imaging Advanced clinical applications transforming patient care Unparalleled networking opportunities with global thought leaders Who Should Attend? The 2026 SNMMI Annual Meeting will feature groundbreaking research and clinical innovation. This critical event unites physicians, technologists, pharmacists,... |
4 events,
-
Taking a recombinant protein from milligrams to GMP-ready scale is where development programs truly succeed or fail. Join this expert-led webinar to explore the critical decision points that impact scalability, quality, CMC readiness, and time to clinic, with real-world insights you can apply immediately. Key learning objectives: - Navigate expression system selection (microbial, mammalian and...
Free
-
Recombinant proteins might feel “done” at milligram scale, but that’s where the real complexity begins. Moving from early design to a scalable, GMP-ready process involves critical decisions that shape yield, quality, timelines, and cost. In this webinar, 3PBIOVIAN will break down three key inflection points that determine whether programs progress smoothly or face costly setbacks....
Free
|
11 events,
Featured
By invitation only. You must be pre-registered by your Jefferies representative in order to attend. The Jefferies Global Healthcare Conference in New York will take place on Tuesday, June 2 – Thursday June 4, 2026. This year’s conference will focus on life sciences companies in the biotechnology, life sciences tools and services, medical technology, and... Future BioTech Expo is a purpose built international exhibition and conference dedicated to red biotechnology and the science transforming how we prevent, diagnose, and treat disease. Held at the Hilton Houston North on June 2–3, 2026, #FBE26 unites pharma innovators, clinical researchers, biotech CEOs, investors, and policymakers under one roof in one of America's fastest growing...
-
What You'll Learn: How does life sciences continue to be Boston’s and Cambridge's economic engine amid a softening market? With total VC investment at $6.85B across 197 rounds in 2025, is capital concentrating into fewer winners, and how is that changing tenant decision making? Where are AI enabled life sciences users, automation heavy labs, and data...
-
Technology transfer for injectable drug products is a pivotal moment that can either accelerate progress or introduce costly delays. This webinar explores how early, strategic alignment across formulation, manufacturing, quality, and primary packaging can reduce risk and improve predictability when transferring programs to a CDMO. Discover how a system-based approach to prefillable syringe packaging, including...
Free
-
This webinar shows how a system-based primary packaging approach—like the West Synchrony™ prefillable syringe system—can streamline tech transfer, simplify GMP qualification, and reduce complexity, cost, and timelines for injectable drug manufacturing. Key Learning Objectives: - How injectable technology transfer impacts project timelines, cost, and risk when working with a CDMO - Where primary packaging decisions...
Free
|
9 events,Connecting Translational Science with the Right Partners to Advance Drug Development Join VCs, biopharma decision-makers and academic innovators in Seattle, June 2026, for the 3rd BioCentury Grand Rounds – U.S. This R&D conference brings together leaders at the forefront of translational science to explore the breakthroughs, bottlenecks and strategies shaping the future of drug development.... From data to decisions. From discovery to better patient outcomes. The Festival of Genomics, Biodata & AI returns to Boston at a critical moment for the US life sciences community. Funding pressures, rising development costs and intensifying competition are colliding with an unprecedented opportunity: the convergence of multi-omics, large-scale biodata and artificial intelligence. To stay ahead, organizations must do...
-
Reimagine what's possible—together. Join BSI Consulting for an expert-led forum designed for pharma and biotech professionals who are shaping the next era of EHS. Connect with peers, challenge assumptions, and explore practical solutions to the industry's most pressing risks and opportunities. This event brings together leaders at the forefront of life sciences in EHS to...
-
The webinar also highlights the growing role of AI within regulated manufacturing environments. Rather than treating AI as an add-on, the session outlines how to embed it into validated frameworks to support predictive maintenance, yield optimization, and faster product release cycles.
Free
-
This webinar will discuss the latest innovation in the GS® Expression System. We will discuss how Lonza’s advanced vector technology in elevates protein expression performance through improved glutamine synthetase selection stringency combined with a high-strength gene promoter to control product expression. We'll show how this novel approach to vector design leads to higher titer and...
Free
|
8 events,Dive into the future of aging with cutting-edge AI breakthroughs at this can’t-miss summit! June 4–5, 2026 | BioLabs@NYU Langone, Long Island City, Queens Longevity science is at an inflection point. Foundation models are learning the language of biology, aging clocks are quantifying human health with new precision, and a generation of therapeutics and clinical...
-
Technology transfer to a CDMO is rarely as simple as handing over a data package. From documentation gaps and equipment differences to method variability and global standards, many programs encounter avoidable risks that can derail timelines and increase cost. In this Outsourced Pharma Live session, industry experts share practical strategies to help sponsors better prepare...
Free
-
Immune checkpoint inhibitors have transformed cancer treatment, but response rates remain limited, and immune-related toxicities continue to pose challenges. Gene editing of therapeutic T cells offers a promising path to help enhance specificity and safety by directly modulating checkpoint expression. In this webinar, we explore how gene-edited T cells targeting PD-1 and TIGIT can improve...
-
Bringing innovative antibody therapeutics to market quickly requires more than upstream efficiency. It demands adaptable and robust downstream purification strategies. As novel mAb formats increase in complexity, purification challenges grow. Achieving required purity and yield often extends beyond traditional 2–3 step platform processes, requiring expanded chromatography options and optimized buffer systems. In this webinar, we... |
1 event,CYTO 2026, the 39th annual Congress of the International Society for the Advancement of Cytometry, is the premier, inclusive, and international conference on the many facets of cytometry science and engineering. Guided by this year's theme, Cytometry: The Next Wave, the meeting will showcase groundbreaking innovations and emerging directions shaping the field. Join us in West... |
